Lehrstuhl für Genetik

Releasing the brakes: targeting FcγRIIB on B cells to enhance antibody-dependent lymphoma immunotherapy. (2015) Seeling M, Nimmerjahn F Journal article, other Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita. (2015) Hirose M, Tiburzy B, Ishii N, Pipi E, Wende S, Rentz E, Nimmerjahn F, et al. Journal article Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. (2015) Harre U, Lang S, Pfeifle R, Rombouts Y, Frühbeißer S, Amara K, Bang H, et al. Journal article Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. (2015) Washburn N, Schwab I, Ortiz D, Bhatnagar N, Lansing JC, Medeiros A, Tyler S, et al. Journal article Dickkopf-3 Acts as a Modulator of B Cell Fate and Function (2015) Ludwig J, Federico G, Prokosch S, Kueblbeck G, Schmitt S, Klevenz A, Groene HJ, et al. Journal article Intravenous immunoglobulin in neurology--mode of action and clinical efficacy. (2015) Luenemann JD, Nimmerjahn F, Dalakas MC Journal article, Review article A New Mouse Model of Junctional Epidermolysis Bullosa: The LAMB3 628G > A Knockin Mouse (2015) Hammersen J, Hou J, Wünsche S, Brenner S, Winkler T, Schneider H Journal article, Original article Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. (2015) Yamada DH, Elsaesser H, Lux A, Timmerman JM, Morrison SL, De La Torre JC, Nimmerjahn F, Brooks DG Journal article No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer. (2015) Lux A, Nimmerjahn F Journal article Siglec-G is a B-1 cell inhibitory receptor and also controls B cell tolerance (2015) Nitschke L Conference contribution